Research News

The George Washington University will participate in a clinical trial for an investigational COVID-19 vaccine.

A recent review published by GW researchers suggests that nitric oxide has promise as a therapeutic to control the replication and rapid spread of SARS-CoV-2.

Rebecca Lynch, PhD, was awarded $3.6 million to investigate HIV-1 resistance to antibody treatments.

A review recently published in JAMA Network Open suggests that environmental exposures like air pollution and heat are associated with adverse pregnancy outcomes, such as preterm birth, low birth weight, and stillbirth.

A recent survey published in AJOB Empirical Bioethics suggests that a physician's behavior on social media may have an impact on patient trust.

The George Washington University (GW) School of Medicine and Health Sciences (SMHS) was recently awarded its first-ever National Institutes of Health T-32 research training grant from the National Cancer Institute (NCI) in support of the GW Cancer Biology Training Program.

Researchers at GW will investigate the changes that occur in the ventral tegmental area of the brain, where dopamine neurons are located, during chronic stress.

Dermatology fellows Chapman Wei and Kamaria Nelson, MD, were awarded research grants from La Fondation La Roche-Posay.

Researchers at the George Washington University found that inhibitory GABAergic interneurons in the hippocampus excite the developing brain at ages equivalent to the early third trimester.

Research led by Nadine Mbuyi, MD, found that gout patients spend longer time in the ED than the national median across all medical illnesses.